Cosmetics OEM business utilizing in-house manufacturing technology
First written in FY2016. 3 of 7 entries say "Advanced", first in FY2020-Q1. Latest entry: FY2026.
Bruno moved to the "Worse" side of this theme in 2023.
0 other companies' latest entry also says "Softened".
- FY2026SoftenedAnnual report
「Following the decision to withdraw from our Relent Cosmetics business and liquidate our consolidated subsidiary, Bruno International Trading (Shenzhen) Co., Ltd., we assessed the recoverability of the related inventories and recognized an inventory valuation loss of ¥60 million as an extraordinary loss.」
For the former in-house cosmetics manufacturing and OEM-related business, the company decided to withdraw from the Relent Cosmetics business and recognized an impairment loss on related inventory. - FY2024-Q1ReframedAnnual report
「Business activities: comprehensive planning and development in the beauty sector; planning of various products and OEM (original) products; cosmetics manufacturing and sales」
Following the closure of its own plant, the Group brought cosmetics planning, OEM and manufacturing and sales functions into the Group through the conversion of Japan Gals into a wholly owned subsidiary, separate from its former cosmetics manufacturing platform. - FY2020AdvancedAnnual report
「Profit attributable to owners of the parent was ¥189 million, compared with ¥168 million in the previous consolidated fiscal year, due to the recognition of costs related to store closures during the spread of COVID-19, impairment losses at some stores, costs related to the closure of the Saitama cosmetics plant and other items.」
Costs related to the closure of the company's own plant were recognized as extraordinary losses for the full year, indicating that the plant closure was reflected in earnings disclosures. - FY2020-Q2AdvancedAnnual report
「Loss on disposal of fixed assets: ¥5 million; plant closure loss: ¥14 million」
Losses related to the closure of the company's own plant included a ¥5 million loss on disposal of fixed assets and a ¥14 million plant closure loss. - FY2020-Q1AdvancedAnnual report
「Extraordinary losses included a ¥3 million loss on disposal of fixed assets, a ¥9 million plant closure loss and a ¥0 million recall loss.」
Following the decision to close the company's own plant, a ¥9 million plant closure loss was recognized as an extraordinary loss in the first quarter. - FY2019Decision to close the company's own plantAnnual report
「Because the recoverable amount of the company's own plant in the manufacturing wholesale business declined significantly following the decision to close it, the carrying amount of the asset group related to the manufacturing wholesale business was reduced to its recoverable amount, and the reduction of ¥18 million was recognized as an impairment loss under extraordinary losses.」
The disclosure describes the decision to close a plant with in-house manufacturing technology and the related recognition of an impairment loss. - FY2016First statedAnnual report
「We also operate an OEM business leveraging our in-house manufacturing technology, with production lines capable of meeting clients' needs in terms of product variety, volume, delivery schedules and other requirements.」
The company explains that its Relent Cosmetics business has a domestic in-house plant and OEM production lines.